Latest Period
Q1 2026
Security Snapshot
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) Institutional Ownership
CUSIP: 15673T100
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
72
Shares (Excl. Options)
138,751,378
Price
$2.26
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- IPSC on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 138,751,378
- Total 13F value
- $312,461,788
- Portfolio coverage rank
- 0%
- Share change
- +108,718,791
- Value change
- +$246,781,720
- Number of holders
- 72
- Shares outstanding
- 180,747,818
- SEC-reported price per share
- $2.28
- Insider filing price
- $2.28
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 15673T100.
- 72 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 46 to 72 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $25,569,840 to $312,461,788.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 72 institutions filings for Q1 2026.
Security key
15673T100
Latest holder period
Q1 2026
13F holders
72
13D/G owners
9
CIK / CUSIP context first
Open Q1 2026 holders
IPSC full holder history
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Century Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15673T100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
IPSC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $16,997,172 | 17,944,649 | RA Capital Management, L.P. | 09 Jan 2026 | |||
| TCG Crossover GP II, LLC | 9.9% | $15,978,987 | 17,754,430 | Chen Yu | 09 Jan 2026 | |||
| Deep Track Capital, LP | 7.3% | $12,137,760 | 13,486,400 | Deep Track Capital, LP | 08 Jan 2026 | |||
| Venrock Healthcare Capital Partners III, L.P. | 7.1% | +48% | $12,354,782 | +$8,606,536 | 13,043,478 | +230% | Venrock Healthcare Capital Partners III, L.P. | 09 Jan 2026 |
| RTW INVESTMENTS, LP | 7.1% | $29,608,695 | 13,043,478 | RTW Investments, LP | 31 Mar 2026 | |||
| Commodore Capital LP | 7.1% | $12,354,782 | 13,043,478 | Commodore Capital LP | 09 Jan 2026 | |||
| Point72 Asset Management, L.P. | 3.3% | -50% | $13,539,819 | +$7,071 | 5,964,678 | +0.05% | Point72 Asset Management, L.P. | 31 Mar 2026 |
| Bain Capital Life Sciences Opportunities III, LP | 4.1% | $1,762,227 | 3,538,609 | Bain Capital Life Sciences Opportunities III, LP | 30 Sep 2025 | |||
| Casdin Capital, LLC | 3.7% | $1,702,527 | 3,212,316 | Casdin Capital, LLC | 31 Mar 2025 |
As of 31 Mar 2026, 72 institutional investors reported holding 138,751,378 shares of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC). This represents 77% of the company’s total 180,747,818 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
74%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.8% | 17,754,430 | 0.43% | $40,125,012 | |
| TCG Crossover Management, LLC | 9.8% | 17,754,430 | 1.1% | $39,021,574 | |
| Versant Venture Management, LLC | 6.7% | 12,166,109 | 19% | $27,495,406 | |
| Deep Track Capital, LP | 5.2% | 9,487,745 | 0.44% | $21,442,304 | |
| Venrock Adviser, LLC | 4.8% | 8,695,652 | 0.73% | $19,652,174 | |
| RTW INVESTMENTS, LP | 4.8% | 8,695,652 | 0.2% | $19,652,174 | |
| Commodore Capital LP | 4.8% | 8,695,652 | 1.1% | $19,652,174 | |
| Point72 Asset Management, L.P. | 3.3% | 5,964,678 | +0.05% | 0.02% | $13,480,172 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1% | 5,686,204 | 0% | 0% | $12,850,821 |
| Balyasny Asset Management L.P. | 2.8% | 5,017,733 | 0.02% | $11,340,077 | |
| MILLENNIUM MANAGEMENT LLC | 2.6% | 4,667,063 | +665% | 0.01% | $10,547,562 |
| Spruce Street Capital LP | 2.2% | 4,059,054 | +186% | 2.2% | $9,173,462 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.1% | 3,789,538 | +106% | 0.01% | $8,564,356 |
| Woodline Partners LP | 1.7% | 3,043,478 | 0.03% | $6,878,260 | |
| Seven Fleet Capital Management LP | 1.6% | 2,947,826 | 2.1% | $6,662,087 | |
| Trails Edge Capital Partners, LP | 1.4% | 2,449,993 | 1.3% | $5,536,984 | |
| DAFNA Capital Management LLC | 1.3% | 2,434,353 | -13% | 1.3% | $5,501,638 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 2,371,430 | +59% | 0% | $5,359,432 |
| BlackRock, Inc. | 0.84% | 1,524,422 | +153% | 0% | $3,445,194 |
| DV Trading LLC | 0.77% | 1,400,000 | 0.29% | $3,164,000 | |
| Rock Springs Capital Management LP | 0.72% | 1,304,347 | 0.17% | $2,947,824 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.72% | 1,301,664 | +185% | 0% | $2,943,265 |
| Casdin Capital, LLC | 0.68% | 1,228,190 | 0% | 0.21% | $2,775,709 |
| Syncona Portfolio Ltd | 0.67% | 1,213,056 | 0% | 11% | $2,741,507 |
| RENAISSANCE TECHNOLOGIES LLC | 0.5% | 906,827 | -33% | 0% | $2,049,429 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 138,751,378 | $312,461,788 | +$246,781,720 | $2.26 | 72 |
| 2025 Q4 | 25,712,702 | $25,569,840 | +$6,410,887 | $0.99 | 46 |
| 2025 Q3 | 20,280,322 | $10,103,490 | -$1,188,475 | $0.50 | 53 |
| 2025 Q2 | 22,628,192 | $12,642,486 | -$3,582,180 | $0.56 | 64 |
| 2025 Q1 | 29,565,044 | $14,071,235 | -$4,277,613 | $0.48 | 69 |
| 2024 Q4 | 36,396,514 | $36,761,199 | -$7,768,598 | $1.01 | 70 |
| 2024 Q3 | 39,649,193 | $67,797,499 | -$1,211,276 | $1.71 | 66 |
| 2024 Q2 | 40,117,934 | $102,301,880 | +$40,961,743 | $2.55 | 59 |
| 2024 Q1 | 23,113,173 | $96,605,177 | +$22,882,584 | $4.18 | 66 |
| 2023 Q4 | 17,675,436 | $58,683,678 | -$543,594 | $3.32 | 60 |
| 2023 Q3 | 18,060,757 | $36,118,983 | -$2,770,150 | $2.00 | 53 |
| 2023 Q2 | 19,290,007 | $60,957,915 | -$2,350,461 | $3.16 | 62 |
| 2023 Q1 | 20,016,851 | $69,456,630 | -$4,620,580 | $3.47 | 63 |
| 2022 Q4 | 20,893,156 | $107,178,277 | -$3,631,215 | $5.13 | 65 |
| 2022 Q3 | 21,098,040 | $208,661,435 | -$4,940,964 | $9.89 | 52 |
| 2022 Q2 | 21,756,667 | $182,752,181 | -$3,241,178 | $8.40 | 51 |
| 2022 Q1 | 22,151,698 | $278,859,136 | +$11,504,710 | $12.59 | 51 |
| 2021 Q4 | 21,137,514 | $335,200,000 | +$24,348,825 | $15.86 | 50 |
| 2021 Q3 | 19,798,633 | $496,205,288 | +$62,122,502 | $25.16 | 47 |
| 2021 Q2 | 16,881,896 | $490,834,435 | +$490,834,432 | $29.34 | 35 |